These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21882010)

  • 1. Can we predict and prevent adverse events related to high-voltage implantable cardioverter defibrillator lead failure?
    Ricci RP; Pignalberi C; Magris B; Aquilani S; Altamura V; Morichelli L; Porfili A; Quarta L; Saputo F; Santini M
    J Interv Card Electrophysiol; 2012 Jan; 33(1):113-21. PubMed ID: 21882010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead.
    Kallinen LM; Hauser RG; Lee KW; Almquist AK; Katsiyiannis WT; Tang CY; Melby DP; Gornick CC
    Heart Rhythm; 2008 Jun; 5(6):775-9. PubMed ID: 18534361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead integrity alert algorithm decreases inappropriate shocks in patients who have Sprint Fidelis pace-sense conductor fractures.
    Kallinen LM; Hauser RG; Tang C; Melby DP; Almquist AK; Katsiyiannis WT; Gornick CC
    Heart Rhythm; 2010 Aug; 7(8):1048-55. PubMed ID: 20493965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.
    Hauser RG; Hayes DL
    Heart Rhythm; 2009 May; 6(5):605-10. PubMed ID: 19285920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead.
    Hauser RG; Kallinen LM; Almquist AK; Gornick CC; Katsiyiannis WT
    Heart Rhythm; 2007 Jul; 4(7):892-6. PubMed ID: 17599673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads.
    Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Stadler RW; Gillberg JM; Patel AS; Ellenbogen KA
    Circulation; 2008 Nov; 118(21):2122-9. PubMed ID: 18981299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads.
    Ellenbogen KA; Gunderson BD; Stromberg KD; Swerdlow CD
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1169-77. PubMed ID: 24099976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards eradication of inappropriate therapies for ICD lead failure by combining comprehensive remote monitoring and lead noise alerts.
    Ploux S; Swerdlow CD; Strik M; Welte N; Klotz N; Ritter P; Haïssaguerre M; Bordachar P
    J Cardiovasc Electrophysiol; 2018 Aug; 29(8):1125-1134. PubMed ID: 29858871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of remote monitoring on reducing the burden of inappropriate shocks related to implantable cardioverter-defibrillator lead fractures: insights from a French single-centre registry.
    Souissi Z; Guédon-Moreau L; Boulé S; Kouakam C; Finat L; Marquié C; Brigadeau F; Wissocque L; Mouton S; Montaigne D; Klug D; Kacet S; Lacroix D
    Europace; 2016 Jun; 18(6):820-7. PubMed ID: 26498163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of implantable cardioverter-defibrillator leads: a matter of lead size?
    Rordorf R; Poggio L; Savastano S; Vicentini A; Petracci B; Chieffo E; Klersy C; Landolina M
    Heart Rhythm; 2013 Feb; 10(2):184-90. PubMed ID: 23063430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead electrical parameters may not predict integrity of the Sprint Fidelis ICD lead.
    Maytin M; Epstein LM
    Heart Rhythm; 2012 Sep; 9(9):1446-51. PubMed ID: 22537883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead.
    Morrison TB; Rea RF; Hodge DO; Crusan D; Koestler C; Asirvatham SJ; Bradley D; Shen WK; Munger TM; Hammill SC; Friedman PA
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):671-7. PubMed ID: 20082653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age.
    Girerd N; Nonin E; Pinot J; Morel E; Flys C; Scridon A; Chevalier P
    Arch Cardiovasc Dis; 2011; 104(6-7):388-95. PubMed ID: 21798471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee.
    Krahn AD; Champagne J; Healey JS; Cameron D; Simpson CS; Thibault B; Mangat I; Tung S; Sterns L; Birnie DH; Exner DV; Parkash R; Sivakumaran S; Davies T; Coutu B; Crystal E; Wolfe K; Verma A; Stephenson EA; Sanatani S; Gow R; Connors S; Paredes FA; Essebag V;
    Heart Rhythm; 2008 May; 5(5):639-42. PubMed ID: 18452862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating risk of Fidelis lead fracture.
    Farwell D; Green MS; Lemery R; Gollob MH; Birnie DH
    Heart Rhythm; 2008 Oct; 5(10):1375-9. PubMed ID: 18783996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sprint Fidelis implantable cardioverter-defibrillators lead patient management and survival: Single center study.
    Grabowski M; Rokicki JK; Gajda S; Januszkiewicz Ł; Cacko A; Stolarz P; Opolski G
    Cardiol J; 2017; 24(3):259-265. PubMed ID: 27910085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.
    Ellis CR; Rottman JN
    Heart Rhythm; 2009 May; 6(5):619-24. PubMed ID: 19389648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of longevity and clinical outcomes of implantable cardioverter-defibrillator leads among manufacturers.
    Kawada S; Nishii N; Morimoto Y; Miyoshi A; Tachibana M; Sugiyama H; Nakagawa K; Watanabe A; Morita H; Ito H
    Heart Rhythm; 2017 Oct; 14(10):1496-1503. PubMed ID: 28502870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.